Ossianix presents a poster “ Combined
in vivo/in vitro methods for selecting VNARs that shuttle large molecules across the blood brain barrier
” and a talk “ Delivery of CD20 (Rituximab)-Transferrin Receptor VNAR Bispecific Antibody to the Brain for Treatment of MS and Brain Cancer
” at the Protein and Antibody Engineering Summit Europe 2016 in Lisbon.